Delivery of peptides and proteins through the blood–brain barrier

U Bickel, T Yoshikawa, WM Pardridge - Advanced drug delivery reviews, 2001 - Elsevier
… endothelial subcellular organelles involved in BBB transcytosis have recently been identified
using electron microscopy and gold conjugates of the OX26 monoclonal antibody [U. Bickel

How to measure drug transport across the blood-brain barrier

U Bickel - NeuroRx, 2005 - Springer
… Samii A, Bickel U, Stroth U, Pardridge WM. Blood-brain barrier transport of neuropeptides: …
Engkvist O, Wrede P, Rester U. Prediction of CNS activity of compound libraries using …

Sniffing neuropeptides: a transnasal approach to the human brain

J Born, T Lange, W Kern, GP McGregor, U Bickel… - Nature …, 2002 - nature.com
Neuropeptides act as neuronal messengers in the brain, influencing many neurobehavioral
functions 1. Their experimental and therapeutic use in humans has been hampered because…

Low-molecular-weight polyethylenimine as a non-viral vector for DNA delivery: comparison of physicochemical properties, transfection efficiency and in vivo …

…, A von Harpe, D Fischer, H Petersen, U Bickel… - Journal of Controlled …, 2003 - Elsevier
Low-molecular-weight polyethylenimine (LMW-PEI) was synthesized by the acid-catalyzed,
ring-opening polymerization of aziridine and compared with commercially available high-…

Targeting rat anti-mouse transferrin receptor monoclonal antibodies through blood-brain barrier in mouse

HJ Lee, B Engelhardt, J Lesley, U Bickel… - … of Pharmacology and …, 2000 - ASPET
Drug targeting through the brain capillary endothelium, which forms the blood-brain barrier (BBB)
in vivo, may be achieved with peptidomimetic monoclonal antibodies that target …

Acute endocrine failure after brain death?

HJ Gramm, H Meinhold, U Bickel, J Zimmermann… - …, 1992 - journals.lww.com
… ACTH was assayed according to Bickel et al. (17). Antibody was obtained from the IgG …
Bickel U, Born J, Fehm HL, Distler M, Voigt KH. The behaviorally active peptide ACTH 4-10: …

Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery.

U Bickel, T Yoshikawa, EM Landaw… - Proceedings of the …, 1993 - National Acad Sciences
… correction for trichloroacetic acid precipitability and intravascular content, the volume of
distribution (VD) of 125I-bioVIPa-avidinOX26 in brain postvascular supernatant was 32 ± 7 ,u/g …

The structure of PEG-modified poly (ethylene imines) influences biodistribution and pharmacokinetics of their complexes with NF-κB decoy in mice

…, D Fischer, K Voigt, T Kissel, U Bickel - Pharmaceutical …, 2002 - Springer
Purpose. To study the relationship between structure of poly(ethylene imine-co-ethylene
glycol), PEI-PEG, copolymers and physicochemical properties as well as in vivo behavior of …

Effect of poly (ethylene imine) molecular weight and pegylation on organ distribution and pharmacokinetics of polyplexes with oligodeoxynucleotides in mice

…, B Osburg, H Petersen, T Kissel, U Bickel - Drug Metabolism and …, 2004 - ASPET
… Arterial blood samples were drawn after nine different time points from 20 s to 120 min, and
the sample volume (30 μl) was replaced immediately with physiologic saline containing 10 U/…

Brain microvascular and astrocyte localization of P‐glycoprotein

…, PL Golden, YS Kang, U Bickel - Journal of …, 1997 - Wiley Online Library
The hypothesis that P‐glycoprotein plays a functional role at the brain capillary endothelium,
which makes up the blood‐brain barrier in vivo, is based largely on immunocytochemical …